Publications by authors named "Rachel Hobson"

Claim this Profile
N
Neuronal hyperactivity becomes mTORC1 independent due to transcriptional changes in tuberous sclerosis complex disease models.
Wardiya Afshar-Saber, Juan F Ruiz, Isabel Gisser, Ziqin Yang, Leena Mehendale, Rachel Hobson

Cell Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LMSz method - an automatable scalable approach to constructing gene-specific growth charts in rare disorders.
Karen J Low, Julia Foreman, Rachel J Hobson, Hannah Kwuo, Elena Martinez-Cayuelas

Eur J Hum Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasibility study evaluating the usability and acceptability of the personalised space technology exercise platform mobile application.
Hannah M Worboys, Laura J Gray, Sarah Anthony, Rachel Hobson, Tim Lucas

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curating genomic disease-gene relationships with Gene2Phenotype (G2P).
T Michael Yates, Morad Ansari, Louise Thompson, Sarah E Hunt, Elena Cibrian Uhalte, Rachel J Hobson

Genome Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the usability and acceptability of the P-STEP® mobile app: feasibility study protocol.
Hannah Worboys, Laura Gray, Sarah Anthony, Rachel Hobson, Tim Lucas

Pilot Feasibility Stud· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland.
Caroline F Wright, Patrick Campbell, Ruth Y Eberhardt, Stuart Aitken, Daniel Perrett, Rachel J Hobson

N Engl J Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
Ahmed J Yousuf, Seid Mohammed, Liesl Carr, Mohammadali Yavari Ramsheh, Claudia Micieli, Rachel Hobson

Lancet Respir Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial.
Thomas A Kite, Amerjeet S Banning, Andrew Ladwiniec, Chris P Gale, John P Greenwood, Rachel Hobson

BMJ Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arthroscopic hip surgery compared with personalised hip therapy in people over 16 years old with femoroacetabular impingement syndrome: UK FASHIoN RCT.
Damian R Griffin, Edward J Dickenson, Felix Achana, James Griffin, Joanna Smith, Rachel Hobson

Health Technol Assess· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial.
Damian R Griffin, Edward J Dickenson, Peter D H Wall, Felix Achana, Jenny L Donovan, Rachel Hobson

Lancet· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapy-led care for femoroacetabular impingement (FAI): the Australian FASHIoN trial.
Nicholas J Murphy, Jillian Eyles, Kim L Bennell, Megan Bohensky, Alexander Burns, Rachel Hobson

BMC Musculoskelet Disord· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalised Hip Therapy: development of a non-operative protocol to treat femoroacetabular impingement syndrome in the FASHIoN randomised controlled trial.
Peter Dh Wall, Edward J Dickenson, David Robinson, Ivor Hughes, Alba Realpe, Rachel Hobson

Br J Sports Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin E and wound healing: an evidence-based review.
Rachel Hobson

Int Wound J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care.
Damian Griffin, Peter Wall, Alba Realpe, Ann Adams, Nick Parsons, Rachel Hobson

Health Technol Assess· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.
Mark Powis, Boo Messahel, Rachel Hobson, Peter Gornall, Jenny Walker

J Pediatr Surg· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004.
Mary M Taj, Nedim Hadzic, Susan E Height, Andrew Wotherspoon, Margaret Burke, Rachel Hobson

Leuk Lymphoma· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.
Marie-Cécile Le Deley, Angelo Rosolen, Denise M Williams, Keizo Horibe, Grazyna Wrobel, Rachel Hobson

J Clin Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists and nurses as independent prescribers: exploring the patient's perspective.
Rachel J Hobson, Jenny Scott, Jane Sutton

Fam Pract· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.
Boo Messahel, Richard Williams, Antonia Ridolfi, Roger A'hern, William Warren, Rachel Hobson

Eur J Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
Hervé Rubie, Julia Chisholm, Anne Sophie Defachelles, Bruce Morland, Caroline Munzer, Rachel Hobson

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists.
Rachel Jane Hobson, Graham J Sewell

Pharm World Sci· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplementary prescribing by pharmacists in England.
Rachel J Hobson, Graham J Sewell

Am J Health Syst Pharm· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized non-Hodgkin's lymphoma with B-cell histology: cure without cyclophosphamide? A report of the United Kingdom Children's Cancer Study Group on studies NHL 8501 and NHL 9001 (1985-1996).
G A Amos Burke, John Imeson, Rachel Hobson, Mary Gerrard

Br J Haematol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.
Denise M Williams, Rachel Hobson, John Imeson, Mary Gerrard, Keith McCarthy

Br J Haematol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis